FDA Investigator Douglas Florentino
Douglas Florentino has inspections in 2 countries as of 16 Oct 2023. Douglas Florentino has collaborated with a combined 3159 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
67
Last Inspection Date:
16 Oct 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
Country:
United States of America,
India
Co-Investigator(s):
A Williams,
Abby E Pelletier,
Abthony C Warchut,
Alice C Silva,
Alysia M Salonia,
Amber G Wardwell,
Amy M Fitzpatrick,
Ana P Barido,
Andrew M Barlow,
Andrew R Wasko,
Angela E Glenn,
Anna M Brannen,
Anne E Carpenter,
Anthony C Warchut,
Anthony N Onianwa,
Anthony P Costello,
Arie C Menachem,
Arindam Dasgupta, PhD,
Ashley A Segura,
Ashley B Jelonek,
Ashley M Whitehurst,
Bill Tacket, Jr,
Bogdan Kurtyka,
Bradley D Newsad,
Brenda P King,
Brenna L Macdowell,
Brunilda Torres,
Byungja E Marciante,
Camerson E Moore,
Carla C Tuite,
Carla E Lavallee,
CDR Rochelle B Young, RPh, MSA,
Celia N Cruz,
Charles A Snipes, PhD,
Charles R Bonapace, PhD,
Charles R Clavet,
Christina Capacci Daniel, PhD,
Christine L Williams,
Christopher J Cruciotti,
Christopher K Vantwuyver,
Christopher M Elliott,
Courtney N Long,
Craig A Garmendia,
Craig T Rybus,
Darin S Wiegers,
Daryl A Dewoskin,
David P Vanhouten,
David R Heiar,
Dawn C Olenjack,
Debre M Emerson,
Diashion E Reid,
Douglas Fiorentino Lcdr,
Dr. Abhijit Raha, PhD,
Dr. Mark J Seaton, PhD,
Dr. Sriram Subramaniam, PhD,
Dr. Zhou Chen (nmi), MD PhD,
Edmund F Mrak, Jr,
Elizabeth B Griffin,
Emily J Schramm,
Erich P Garger,
Gajendiran Mahadevan, PhD,
Garry H Stewart,
Gary J Hagan,
Gary S Hagan,
Gene R Gunn,
George T Allen, Jr,
Gerald Mierle,
Gerard D Difiore,
Hien Albright,
Holly M Scott,
Hugh M Mcclure, II,
Irons,
Jamie S Mathews,
Jana L Caylor,
Jason A Rossi,
Jason D Tenney,
Jennifer L Huntington,
Jessica I Newman,
John A Sciacchitano,
John B Crowe,
John L Zaccone,
John P Shelton,
John R Carlson,
Jonathan B Lewis,
Joppie,
Jose A Torres,
Jose R Rodriguez,
Joseph B Cascio,
Joseph Foley,
Joshua J Silvestri,
Joshua L Gibbs,
Joyce A Kellett,
Karen Mcnabb Noon,
Kathleen E Mcafoose,
Kathleen M Curry,
Keith A Schwartz,
Kenneth H Williams,
Kent A Conforti,
Lauren M Lawrance,
LCDR Debra Emerson,
LCDR Randall L Morris,
Leroy Terrelonge,
Linda R Kuchenthal,
Lindsay R Hatch,
Liz M Otero,
Lorayne A Mcguinness,
LT Richard A Lyght,
Lura D Baquero,
Lura D Kelly,
M Patriciaurphy Murphy,
Marcia M Laughrey,
Margaret E Walsh,
Mark E Farrell,
Mark R Mcclain,
Martin J Guardia,
Mary Jeanet Mcgarry,
Matthew C Watson,
Megan A Haggerty,
Melkamu Getie Kebtie, PhD,
Michael J Pasternak,
Michael P Anthony,
Michael P Sweeney,
Michelle M Noe,
Michelle M Noe Varga,
Mizanne E Lewis,
Nichole B Murphy,
Nicola M Fenty Stewart,
Osama A Khatib,
Pamela L Ogonowski,
Paraluman S Leonin,
Patrick C Klotzbuecher,
Paul P Geraci,
Peter R Lenahan,
Philip H Lafleur,
Philip Kreiter,
Ramcharan S Khalsa,
Robert C Steyert,
Robert J Martin,
Ronnie E Jackson,
Rory K Geyer,
Rupa Pradhan,
Samina S Khan,
Sandra P White,
Scott B Laufenberg,
Sean M Tessicini,
Sean R Marcsisin,
Seth A Mailhot,
Sharmista Chatterjee,
Shawn M Bogdan,
Sherbet L Samuels,
Shirley S Wen,
Slater K Bartlett,
Stacey F Allard,
Stacey F Rivette,
Stacey S Degarmo,
State Agency,
Susanne M Richardson, MSc RAC ELS,
Susanne Mrichardsonmsc Rac,
Teddy Tom,
Thea C Grome,
Thomas J Murphy,
Thomas Siebertz,
Thomas W Nojek,
Timothy C Grome,
Troy R Petrillo,
Victor J Gangi,
Victoria M Daddeo,
Victoria Rosales,
Victoria Taylor,
Vioela J Caze,
Wendy A Johnecheck,
William K Dagley,
Yong Hu
Douglas Florentino's Documents
Publish Date | Document Type | Title |
---|---|---|
October, 2010 | FDA 483 | Pfizer Inc. Groton Laboratories - Form 483, 2010-10-27 |
December, 2007 | FDA 483 | Research Packaging, Inc. - Form 483, 2007-12-19 |
March, 2010 | EIR | Charles River Laboratories, Inc. - EIR, 2010-03-03 |
November, 2022 | FDA 483 | Carlos M. Martinez, M.D. - Form 483, 2022-11-01 |
July, 2021 | FDA 483 | A&M Endeavors, LLC - Form 483, 2021-07-14 |
October, 2009 | FDA 483 | Radius Medical LLC - Form 483, 2009-10-01 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more